Recent performance puts Marcus & Millichap stock in focus

Marcus & Millichap (MMI) has drawn attention after recent share performance, with the stock down about 2.6% on the day and roughly 7.4% over the past week, while showing gains over the month and the past 3 months.

At a share price of $28.18, Marcus & Millichap has seen short term share price pressure ease, tempering some of its recent momentum. The 90 day share price return stands at 9.01%, compared with a 1 year total shareholder return that is down 3.49%.

If the recent swings in commercial real estate have your attention, it can help to broaden your watchlist and check out 19 top founder-led companies

With Marcus & Millichap trading near its analyst price target and carrying a value score of 3, the key question is whether the current share price reflects its future potential or if markets are already pricing in growth.

Most Popular Narrative: 1% Overvalued

The most followed narrative puts Marcus & Millichap’s fair value at $28.00, slightly below the last close at $28.18, framing a near fully priced stock.

The analysts have a consensus price target of $28.0 for Marcus & Millichap based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.1 billion, earnings will come to $63.7 million, and it would be trading on a PE ratio of 20.4x, assuming you use a discount rate of 8.8%.

Curious what revenue path, margin shift and profit multiple have to line up to reach that outcome? The narrative leans on a tight mix of growth, buybacks and valuation re rating. The full set of assumptions shows exactly how those moving parts fit together.

Result: Fair Value of $28 (ABOUT RIGHT)

However, this hinges on transaction heavy revenue and commission fees, where weaker deal activity or fee compression could quickly challenge the current fair value story.

Another Take: Multiples Point To Richer Pricing

While the most popular narrative frames Marcus & Millichap as roughly fairly priced around $28, the P/S ratio tells a different story. At 1.4x sales, the stock sits above its own fair ratio of 0.9x and the peer average of 0.5x, which points to meaningful valuation risk if sentiment cools.

To see how that gap looks when broken down by sales multiples, and where the numbers could move if the market leans closer to the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment clearly split between risks and rewards, this is a moment to act quickly and review the data for yourself, starting with the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If Marcus & Millichap has you thinking harder about valuation and risk, do not stop here. Broaden your watchlist with ideas filtered for quality and resilience.

• Spot potential mispricings by scouting companies screened for quality and valuation using the 50 high quality undervalued stocks.
• Strengthen your focus on balance sheet resilience by reviewing stocks filtered through the solid balance sheet and fundamentals stocks screener (45 results).
• Get ahead of the crowd by checking a screener containing 22 high quality undiscovered gems before others catch on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.